| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |